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In normal conditions gut homeostasis is maintained by the suppressive activity of
regulatory T cells (Tregs), characterized by the expression of the transcription factor
FoxP3. In human inflammatory bowel disease, which is believed to be the consequence
of the loss of tolerance toward antigens normally contained in the gut lumen, Tregs have
been found to be increased and functionally active, thus pointing against their possible
role in the pathogenesis of this immune-mediated disease. Though, in inflammatory
conditions, Tregs have been shown to upregulate the T helper (Th) type 1-related
transcription factor Tbet and to express the pro-inflammatory cytokine IFNγ, thus
suggesting that at a certain point of the inflammatory process, Tregs might contribute
to inflammation rather than suppress it. Starting from the observation that Tregs isolated
from the lamina propria of active but not inactive IBD patients or uninflamed controls
express Tbet and IFNγ, we investigated the functional role of Th1-like Tregs in the dextran
sulfate model of colitis. As observed in human IBD, Th1-like Tregs were upregulated
in the inflamed lamina propria of treated mice and the expression of Tbet and IFNγ in
Tregs preceded the accumulation of conventional Th1 cells. By using a Treg-specific
Tbet conditional knockout, we demonstrated that Tbet expression in Tregs is required
for the development of colitis. Indeed, Tbet knockout mice developed milder colitis and
showed an impaired Th1 immune response. In these mice not only the Tbet deficient
Tregs but also the Tbet proficient conventional T cells showed reduced IFNγ expression.
However, Tbet deficiency did not affect the Tregs suppressive capacity in vitro and in vivo
in the adoptive transfer model of colitis. In conclusion here we show that Tbet expression
by Tregs sustains the early phase of the Th1-mediated inflammatory response in the gut.
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INTRODUCTION
In homeostatic conditions, the gastrointestinal tract is patrolled by immune cells which are in
charge to fight against pathogens. At the same time, the intestinal mucosal immune system tolerates
harmless antigens contained in the gut lumen. The unbalance between these pro-inflammatory and
tolerogenic activities is believed to cause inflammatory bowel disease (IBD), whose main forms are
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Crohn’s disease (CD) and ulcerative colitis (UC). In IBD, antigens
normally contained in the gut lumen derived from the gut
microbiota or introduced with diet, cause an excessive activation
of the immune system leading to chronic inflammation and
irreversible tissue damage (1).
Regulatory T cells (Tregs) are a class of T cells which
negatively control the pro-inflammatory activity of adaptive
and innate immune cells and they play a key role in
the maintenance of the gut immune homeostasis (2).
In the absence of Tregs, as observed in case of loss-
of-function mutations of the Tregs lineage committing
transcription factor foxp3 (i.e., IPEX syndrome in humans,
scurfy mice) (3, 4), or in case of functional mutations
of genes encoding for molecules involved in the Tregs
suppressive activity such as CTLA4 and IL10, an uncontrolled
activation of the immune system in the gut is invariantly
observed (5–7).
Despite the pivotal role of Tregs in the maintenance of gut
homeostasis, the number of Tregs is not reduced in the lamina
propria of IBD patients and they result even increased in the
inflamed areas (8, 9). Moreover, Tregs isolated from IBD patients
were shown to be as suppressive as Tregs isolated from non-IBD
controls (10). Therefore, the role of Tregs in the pathogenesis of
IBD remains elusive.
Although considered finally differentiated cells, Tregs have
been recently shown to have a certain functional plasticity.
For instance, Tregs can acquire the expression of the master
transcription factors that define the T helper cell subsets they
are suppressing (11, 12). In this context, the expression of Tbet
by Tregs, as observed in Th1 immune responses induced by
Mycobacterium sp. infection, has been shown to induce the
expression of the chemokine receptor CXCR3 and to promote
the Tregs homing at the site where Th1 cells need to be kept in
check (13).
Although Tbet expressing Tregs do not normally
secrete pro-inflammatory cytokines and maintain their
suppressive capacity, in certain conditions they can acquire
a Th1-like phenotype characterized by IFNγ secretion
and pro-inflammatory functions (14, 15). Moreover,
several reports indicate that IFNγ -expressing Th1-
like Tregs are involved in the pathogenesis of different
inflammatory diseases (16–18). Although IFNγ expressing
Th1-like Tregs have been described in models of intestinal
inflammation (19, 20), the presence of these cells in human
IBD and their functional role in intestinal inflammation
remain unclear.
Here, we provide evidence that IFNγ-expressing cells
accumulate in the inflamed tissue of both CD and UC patients.
We also demonstrate that mice developing chemically-induced
colitis are characterized by an increased number of IFNγ-
expressing Th1-like Tregs in the intestinal lamina propria
and that their upregulation precedes the accumulation
of conventional Th1 cells. Finally, by generating Treg-
specific Tbet conditional knockout mice, we demonstrate
that pro-inflammatory Th1-like Tregs are required for the
development of intestinal inflammation.
MATERIALS AND METHODS
Patients
Intestinal biopsies of IBD patients (Ileal CD n = 8; colonic
CD n = 5; active UC n = 7; inactive UC n = 5), and
patients undergoing intestinal surgical resection for pathologies
unrelated to IBD, including intestinal tumors (ileal controls
n= 7; colonic controls n= 5) were obtained from the Policlinico
Tor Vergata, Rome, Italy and IRCCS Ospedale Maggiore
Policlinico di Milano, Milan, Italy. The clinical characteristics
and concomitant therapies of IBD patients are summarized in the
Supplementary Table 1. Disease extent of UC and localization
and behavior of CD were described according to the Montreal
classification for IBD. Local Ethics Committees (Tor Vergata
University Hospital, Rome. Protocol number:154/12).
Mice
All mice used were on C57BL6 genetic background and were
housed and bred under specific pathogen-free conditions in
a facility located in Castel Romano, Rome. To generate the
FoxP3 reporter mice, FoxP3eGFP-Cre knock-in mice (kindly
provided by A. Rudensky, MSKCC, NY, USA) which bear
the coding sequence for the green fluorescent protein/iCre-
recombinase fusion protein knocked-in the FoxP3 locus were
crossed with the Rosa26-tdRFP mice (kindly provided by Hans
Joerg Fehling, University of Ulm, Germany). tdRFP mice bear
a mutation consisting in a reporter allele for Cre activity that
expresses a non-toxic tandem-dimer red fluorescent protein
(tdRFP) following Cre-mediated deletion of a floxed neo/stop
cassette. Treg-specific Tbx21 conditional knockout mice were
generated crossing FoxP3 reporter mice with mice bearing the
floxed Tbx21 allele (Tbx21fl/fl JAX, Bar Harbor, ME, USA).
In these mice, Cre expression, under control of the FoxP3
promoter, cause the deletion of Tbx21 floxed exons leading to
gene inactivation selectively in Tregs. Both FoxP3 reporter and
Treg specific Tbet conditional knockout mouse strains were
vital and born in the expected mendelian ratios with sign of
spontaneous disease up to 12 months. IFNγ knockout mice were
purchased from Jackson Laboratories (JAX, Bar Harbor, ME,
USA). All animal experiments were performed in accordance
with the local institutional guidelines. Male mice (6–8 weeks old)
were used for all the experiments.
Authorization No: 324/2006-PR issued by the Ministry
of Health on 29/03/2016 and in compliance with European
rules (2010/63/UE).
Experimental Colitis
Chemically-induced colitis was induced in FoxP3 reporter,
conditional Tbx21 knockout and IFNγ knockoutmice.Mice were
treated with 2% dextran sulfate sodium (DSS, TdB Consultancy
AB, Uppsala, Sweden) in drinking water for 7 days followed
by normal drinking water until day 10. Body weight was
monitored daily.
Adoptive transfer model of colitis was performed by injecting
i.p. 6–8 weeks old RAG1-deficient mice with 4× 105 FACS sorted
CD4+CD45RBhigh cells from splenocytes of wild type C57BL6
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mice alone or together with the same number of Tregs isolated
from the spleen of FoxP3CreTbx21wt/wt or FoxP3CreTbx21fl/fl
mice. Body weight was monitored every other day.
Endoscopic Procedures
The development of DSS-induced colitis in mice was assessed by
micro-endoscopy as previously described (21).
Histologic Analysis of Colon Cross
Sections
Colonic cross sections were stained with H&E, and the severity of
inflammation was evaluated as previously described (22).
Isolation of Leukocyte Subpopulations and
Flow Cytometry Analysis
Human lamina propria mononuclear cells (LPMC) were isolated
according to standard protocols. Briefly, the dissected intestinal
mucosa was freed of mucus and epithelial cells in sequential
steps with DTT (0.1 mmol/L) and EDTA (1 mmol/L) (both from
Sigma, Milan, Italy) and then digested with collagenase D (400
U/ml) (Worthington Biochemical Corporation, Lakewood, NJ)
for 5 h at 37◦C. LPMCwere then separated with a Percoll gradient
and cultured in complete RPMI 1640 medium containing
5% human serum (Sigma, Milan, Italy) and 100 U/ml IL-2
(Proleukin, Novartis, Switzerland). Cells suspension was stained
with anti-CD4 clone RPA-T4 (Biolegend, San Diego, California),
anti-Foxp3 clone PCH101 (eBioscience, Thermo Fisher scientific,
Italy), anti-Tbet clone 04-46 (BD Pharmigen, Milan, Italy) and
anti IFNγ clone 4s.b3 (Biolegend, San Diego, California) after
5 h stimulation with 40 ng/ml phorbol 12-myristate 13-acetate
(PMA) and 1µg/ml ionomycin (Sigma Aldrich, Milan, Italy), in
the presence of 2 nmol/l monensin (eBioscience, Thermo Fisher,
Italy) according to standard protocols.
Mouse LPMC were obtained according to Lamina Propria
Dissociation Kit mouse protocol (Miltenyi Biotech, Bergisch-
Gladbach, Germany). Colonic Lamina Propria Mononuclear
Cells (LPMC) were stained with LIVE/DEAD R© staining (Life
Technology, Milan, Italy) and with surface fluorochrome-
conjugated antibodies against CD3 clone 500A2, CD4 clone
GK1.5 (BD Pharmingen, Milan, Italy). Permeabilization and
intracellular staining with conjugated anti-Tbet clone Q313778,
anti-IFNγ clone XMG1.2 or anti-IL10 clone JES5-16E3 (BD
Pharmingen, Milan, Italy), were performed after 5 h stimulation
with PMA/ionomycicn. Cells were acquired with a FACS
VERSE R© (BD Bioscience, San Jose, CA) gating on living cells and
the data were analyzed with FlowJo software (BD).
In vitro Induction of Th1-Like Tregs
In some experiments CD4+ T cells were magnetically sorted
from splenocytes by using the CD4+ T Cell Isolation kit mouse
(Miltenyi Biotec, Bergisch Gladbach, Germany) according to
the manufacture’s protocol. At least 97% purity was verified by
flow cytometry before each experiment. To induce Tbet and
IFNγ expression, CD4+ T cells were polyclonally activated in
RPMI 1640 10% FBS (Lonza, Basel, Switzerland) with plate
bound anti-CD3 (clone 145-2C11, eBioscience, Thermo Fisher
scientific, Italy) and 1mg/ml anti CD28 (clone 37.31, eBioscience,
Thermo Fisher scientific, Italy). In some experiment CD4+ T
cells were cultured in the presence of 10 mg/ml anti mouse IFNγ
neutralizing antibody (clone XMG1.2, eBioscience, Thermo
Fisher scientific, Italy) or the isotype control IgG2a. FACS sorted
FoxP3+ Tregs were cultured in RPMI1640 10% FBS for 24 h
in the presence of plate bound anti-CD3, 10µg/ml anti-CD28,
20 ng/ml mouse recombinant (mr)IL2 (R&D Systems, Abingdon,
UK) and 100 ng/ml mrIFNγ or 15 ng/ml mrIL12 or 10 ng/ml
mrIL23 or 20 ng/ml mrIL6 or 50 ng/ml mrIL21 (R&D Systems,
Abingdon, UK).
Cell Proliferation Assay
105 FACS-sorted CD4+CD45RBhigh responder (R) cells were
labeled with CellTrace R©-violet (Thermo Fisher scientific, Italy)
according to manufacturer’s instruction and co-cultured with
sorted CD4+FoxP3+ Tregs suppressor (S) from splenocytes
of FoxP3CreTbx21wt/wt or FoxP3CreTbx21fl/fl at different ratios
in the presence of plate bound anti-CD3 clone 145-2C11 (BD
Pharmigen, Milan, Italy) and 104 sorted CD90- splenocytes
used as antigen-presenting cells. CellTrace R© fluorescence was
evaluated after 5 days co-culture and the fraction of non-
proliferating cells used as suppression index.
RNA Extraction, Complementary DNA
Preparation, and Real-Time PCR
Total RNA was isolated with the PureLink R© RNA Micro Kit
(Thermo Fisher scientific, Italy) for in vitro experiments and
with PureLink R© RNA Mini Kit (Thermo Fisher scientific, Italy)
for tissue, according to the manufacturer’s recommendations.
Reverse transcription into cDNA was performed with the
Superscript III Reverse Transcriptase kit (Invitrogen, Thermo
Fisher scientific, Italy) according to the manufacturer’s
protocol and then amplified by real-time PCR using iQ
SYBR Green Supermix (Bio-Rad Laboratories, Milan, Italy).
PCR was performed by using the primers described in the
Supplementary Table 2. RNA expression was calculated relative
to the housekeeping beta-actin gene expression on the base of
the1Ct algorithm.
Statistics
The Mann Whitney test and the unpaired student’s t-test were
used to evaluate differences between the two experimental
groups after checking for normal distribution of data. Statistically
significant differences between groups are indicated (∗P < 0.05;
∗∗P< 0.01; ∗∗∗P< 0.001). Statistical analysis was done performed
using GraphPad Prism software (Graphpad Software Inc., San
Diego, CA, USA).
RESULTS
Th1-Like Tregs Are Up-Regulated in Active
IBD
In a first set of experiments we aimed to assess the presence of
Th1-like Tregs, characterized by the expression of Tbet and IFN-
γ in the gut of IBD patients. To this end, mucosa biopsies were
collected from the most inflamed intestinal areas of UC (n = 7)
and CD (n= 8) patients. Biopsies from inactive UC (n= 5) were
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FIGURE 1 | Lamina propria (LP) FoxP3+CD4+ T cells from IBD patients express IFNγ. (A) Flow cytometric analysis of IFNγ expression in CD4+FoxP3+ regulatory T
cells (Tregs) and CD4+FoxP3- conventional T cells (ConvT) cells from LP cells of IBD patients and controls: gating strategy. (B) Flow cytometric analysis of IFNγ
expression in Tregs (upper panel) and ConvT (lower panel) from ileal Crohn’s disease (CD; n = 8), control ileum (n = 7), colonic CD (n = 5), active ulcerative colitis (UC;
n = 7), inactive UC (n = 4), and control colon (n = 5). (C,D) Representative dot plot representing FoxP3 and Tbet expression in LP CD4+ T cells (C) and Tbet and
IFNγ expression in LP FoxP3+CD4+ T cells (D) from IBD patients. (E) Frequency of IFNγ+ cells among Tbet+ and Tbet- Tregs in CD (n = 4) and UC (n = 3) patients.
Numbers in the dot plot quadrants and histograms represent the relative frequency of cell subpopulations. Horizontal bars in (B,D) represent the mean value ±SD.
*p < 0.05; **p < 0.01.
also collected. As controls, samples of normal ileal (n = 7) and
colonic mucosa (n = 5) were taken from patients undergoing
surgical resection for colonic neoplasia. As shown in Figure 1A,
IFNγ was expressed in both FoxP3 negative conventional T cells
(ConvT) and Foxp3+ Tregs. As expected, ConvT cells from CD
patients expressed more IFNγ as compared to controls. Similarly,
ConvT cells from active UC expressedmore IFNγ as compared to
both inactive UC and control samples (Figure 1B, upper panel).
Concerning Tregs, about 30% of the FoxP3+ cells from the
inflamed ileal and colonic mucosa of CD patients expressed IFNγ
and their frequency was significantly higher than their relative
controls. In UC, the frequency of Tregs-expressing IFNγ was
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about 20% and this was significantly higher than that observed in
both inactive UC patients and colonic controls (Figure 1B, lower
panel). Similarly to ConvT cells, a proportion of Foxp3+Tregs
from inflamed IBD co-expressed the Th1-related transcription
factor Tbet (Figure 1C) but IFNγ was exclusively expressed by
Tbet+ Tregs in both CD and UC (Figures 1D,E). These results
suggest that Th1-like Tregs, characterized by the expression of
Tbet and IFNγ, might play a role during the inflammatory flares
in IBD patients.
Th1-Like Tregs Are Upregulated in the
Early Phase of Inflammation in the DSS
Model of Colitis
To investigate the functional role of Th1-like Tregs in the
development of intestinal inflammation, we first assessed
whether Tbet-expressing Tregs were generated during intestinal
inflammation induced in mice after oral administration of
dextran sodium sulfate (DSS). This model is characterized by
the induction of a potent Th1 immune response secondary to
the damage of the intestinal epithelial barrier and increased
permeability to luminal antigens. To this end, we used
FoxP3GFP−CreRosa26tdRFP fate mapping reporter mice. In these
mice, Tregs are characterized by the double expression of
eGFP and tdRFP fluorescence (Supplementary Figures 1A,B).
Reporter mice were treated with DSS for 7 days and
sacrificed at day 10, when the peak of inflammation occurred
(Supplementary Figure 1C). At the end of the experiment,
Tbet-expressing Tregs increased in the lamina propria of DSS
treated mice as compared to untreated controls (Figure 2A).
Interestingly, in this early phase of colitis, the frequency of
Tbet positive cells among Treg but not eGFP/tdRFP double
negative ConvT cells increased during inflammation (Figure 2B).
However, in terms of absolute numbers, both Tbet+ ConvT and
Treg cells resulted increased in treated mice as compared to
controls (Figure 2C) thus suggesting that the accumulation of
Tbet-expressing Tregs in the lamina propria during the initial
phase of inflammation might be proportionally greater than
that of ConvT cells. Accordingly, the number of Tbet+ Tregs
represented one third of all the CD4+ Tbet+ cells infiltrating
the lamina propria at this time point as compared to one tenth
in the untreated mice. Since IFNγ expression distinguishes Tbet-
expressing Tregs with Th1-specific suppressive capacity from
Th1-like pro-inflammatory Tregs, we assessed IFNγ expression
by lamina propria Tregs in our model. The frequency of IFNγ
positive cells resulted increased among Tregs in DSS treated mice
as compared to the untreated controls (Figure 2D). Similarly to
Tbet expression, the frequency of IFNγ -positive cells remained
stable among ConvT cells (Figure 2E) while the absolute number
of both ConvT and Treg cells expressing IFNγ resulted increased
in the treated mice, the Th1-like Tregs representing one third
of the total IFNγ-secreting CD4+ T cells (Figure 2F). Taken
together, these data indicate that in a colitis model characterized
by the alteration of the epithelial barrier, Tregs acquire a Th1-like
phenotype characterized by Tbet and IFNγ expression. In order
to investigate how early Th1-like Tregs appeared during colitis
development, we performed a time course experiment in which
mice were sacrificed at day 3, 6, and 10 of the DSS protocol.
At day 3 and 6, DSS treated mice were characterized by none
or mild colitis as shown by histological score of colitis severity
(Figures 3A,B). The frequency of Tbet-expressing Tregs but not
ConvT cells increased by day 6 as compared to untreated mice
when only mild signs of colitis were observed (Figures 3C,D)
prompting us to hypothesize that Th1-like Tregs might represent
a “ready-to-use” source of IFNγ supporting the early stage of
Th1-mediated immune response.
IFN-γ Plays a Non-redundant Role in the
Induction of Th1-Like Tregs Both in vitro
and in vivo
To test the hypothesis that Tbet induction and IFNγ expression
in Tregs might be induced during T cell activation to support the
development of Th1 cells, total CD4+ T cells sorted from the
spleen of FoxP3GFP−CreRosa26tdRFP were polyclonally activated
in vitro for 48 h or left unstimulated, and Tbet and IFNγ
expression evaluated by flow cytometry. Activated but not resting
cells upregulated Tbet and IFNγ in both Treg and ConvT cells
(Figure 4A). Tbet resulted upregulated as early as 12 h after
stimulation in both Tregs and ConvT and their relative number
progressively increased reaching 85 and 60%, respectively, at
48 h (Figure 4B). Tbet expression was higher among Tregs than
ConvT cells at each time point. IFNγ was expressed by a
small fraction of cells after 12 and 24 h and increased at 48 h
(Figure 4C). At this time point, 65 and 25% of Tregs and ConvT
cells, respectively, resulted IFNγ positive. These results indicate
that in the gut, Tregs are poised to rapidly upregulate Tbet
and IFNγ after activation. IFNγ has been shown to induce the
expression of Tbet in FoxP3+ cells. Accordingly, sorted FoxP3+
Tregs failed to upregulate Tbet after activation in the absence
of IFNγ, while the addition of IFNγ to the cell culture medium
but not other cytokines (i.e., IL12, IL23, IL6, or IL23), induced
Tbet expression (Supplementary Figure 2A). To assess whether
IFNγ was required to induce Tbet expression in our in vitro
system, CD4+ T cells were activated in the presence or absence
of neutralizing anti-IFNγ antibodies. In the presence of anti-
IFNγ, Tbet expression and IFNγ secretion were reduced in both
Tregs and ConvT, being the suppressive effect prevalent in the
latter (Figure 5A). Moreover, themagnitude of IFNγ suppression
among ConvT cells resulted bigger than the one observed in
Tregs at each of the analyzed time points (Figures 5B,C).
To confirm in vivo the role of IFNγ in the induction of Th1-
like Tregs during colitis, IFNγhet and IFNγKo mice underwent
the DSS protocol and LPMC were analyzed at day 10. As
previously reported, IFNγKo mice developed milder disease as
shown by the lower weight loss as compared to the IFNγHet
control mice [Supplementary Figure 2B; (23)]. At the end of the
experiment, Tbet expression resulted suppressed in the lamina
propria Tregs of IFNγKo mice as compared to the heterozygous
controls (Figure 5D) thus demonstrating that IFNγ plays a
non-redundant role in the induction of Th1-like Tregs during
intestinal inflammation.
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FIGURE 2 | (A) Representative dot plots showing FoxP3eGFP and Tbet expression in LP CD3+CD4+ T cells isolated from untreated and DSS-treated mice.
Frequency (B) and absolute numbers (C) of Tbet+ cells among total CD4+, Treg and ConvT cells as indicated. (D) Representative FoxP3eGFP and IFNγ expression of
the same cells as in (A). Frequency (E) and absolute (F) numbers of IFNγ+ cells among total CD4+, Treg, and ConvT cells as indicated. Numbers in the dot plot
quadrants represent the relative frequency of cell subpopulations. Horizontal bars indicate the mean, symbols indicate each analyzed mouse. Vertical bars indicate
mean ±SEM. **p < 0.01, ns, not significant.
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FIGURE 3 | (A) Representative histological sections of colons from DSS-treated mice (upper panel 20x magnification, lower panel 40x magnification) at different time
points as indicated. Bars in the pictures indicate the scale. (B) Cumulative histologic score of DSS-treated mice pooled from three independent experiments at
different time points, bars indicate the mean ±SD. (C) Percent of Tbet+ cells among LP Tregs and ConvT cells from DSS-treated mice at different time points,
symbols indicate each analyzed mouse, bars indicate the mean. (D) Tbet+ cells fold increase relative to baseline (day 0) in Tregs and ConvT cells. Numbers in the dot
plot quadrants represent the cell relative frequency. *p < 0.05; **p < 0.01; ns, not significant.
Th1-Like Tregs Are Required for the
Development of DSS Colitis
To assess the role of Th1-like Tregs n the development of
colitis, we crossed FoxP3eGFP−CreRosa26tdRFP mice with
mice carrying floxed TBX21 alleles (TBX21fl/fl) to obtain a
Treg-specific Tbet conditional knockout mouse (from here
on indicated as FoxP3CreTBX21fl/fl). FoxP3CreTBX21fl/fl
and the FoxP3CreTBX21wt/wt mice, used as control, were
treated with DSS as described above. FoxP3CreTBX21fl/fl mice
showed milder weight loss and lower endoscopic grade of
colitis severity as compared to FoxP3CreTBX21wt/wt mice
(Figures 6A,B). Accordingly, at the end of the experiment,
FoxP3CreTBX21fl/fl mice were characterized by milder colitis
than controls, as shown by the histology score (Figure 6C)
and the lower expression of the neutrophil-related marker
lcn-2 mRNA (Figure 6D). The cytokine profile analysis showed
reduced ifnγ and tnfα mRNA expression while no significant
differences were observed in il17a, il6, il22, and il10 expression
(Figure 6E). ifnγ and tnfα, were the most downregulated
cytokines in FoxP3CreTBX21fl/fl mice, with a reduction by
10 and 5-fold respectively (Figure 6F). Finally, il12p35 but
not il23p19 were reduced in knockout mice as compared to
control mice (Figure 6G). These data indicate that the reduced
inflammation observed in FoxP3CreTbx21fl/fl mice was caused
neither by a defect in the Th17-mediated immune response
nor to an increased expression of anti-inflammatory cytokines
but rather by a reduced expression of Th1-related cytokines.
Since the frequency of Tregs, ex-Tregs and ConvT, based on the
expression of the endogenous fluorescence eGFP and tdRFP,
did not differ between Tbet knockout mice and the controls
(Supplementary Figure 3A), to investigate whether the milder
inflammatory phenotype shown by FoxP3CreTbx21fl/fl was due
to the increased suppressive capacity of Tregs in the absence of
Tbet, Tregs from FoxP3CreTbx21fl/fl and FoxP3CreTbx21wt/wt
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FIGURE 4 | Total CD3+CD4+ T cells from the spleen of reporter mice were polyclonally activated in vitro. (A) Representative dot plots representing Tbet and IFNγ
expression gating on Tregs and ConvT after 48 h of stimulation. Tbet and IFNγ isotype control stainings gating on CD4+ cells are shown (upper right plot). Percent of
Tbet+ (B) and IFNγ+ (C) cells among Treg and ConvT cells at different time points. Each point represents the mean ±SD of three independent experiment performed.
were co-cultured with CellTrace R©-violet-labeled wild type
CD45RBhigh naïve T cells used as responder cells. In these
experiments no difference in the suppressive capacity of wild type
and Tbet knockout Tregs cells was observed at each responder-
to-suppressor cell ratios (Supplementary Figure 3B). No
difference was also observed when Tregs from FoxP3CreTbx21fl/fl
and FoxP3CreTbx21wt/wt were used in vivo in the adoptive
transfer model of colitis (Supplementary Figure 3C) as
previously reported (24, 25). Finally, the frequency of IL10-
expressing Tregs isolated from the colon of either DSS-treated
FoxP3CreTbx21fl/fl or FoxP3CreTbx21wt/wt did not differ
(Supplementary Figures 3D,E). These data suggest that
the lower inflammation observed in FoxP3CreTbx21fl/fl
mice is unlikely due to an enhanced suppressive capacity of
Tbet-deficient Tregs.
Conventional Th1 Cells Development
Requires the Presence of Functional
Th1-Like Tregs
In order to assess whether the phenotype shown by
FoxP3CreTBX21fl/fl mice was caused by impaired Th1 cells
in the absence of IFNγ-secreting Th1-like Tregs, LPMC from
FoxP3CreTBX21fl/fl and FoxP3CreTBX21wt/wt mice were isolated
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FIGURE 5 | Total CD3+CD4+ T cells from the spleen of reporter mice were polyclonally activated in the presence of neutralizing anti-IFNγ antibody or control IgG. (A)
Representative dot plots showing Tbet and IFNγ expression on gated Treg and ConvT cells after 24 h of stimulation. Tbet and IFNγ isotype control stainings gating on
CD4+ cells are shown (upper right plot). (B,C) Percent of Tbet+ cells among Treg (B) and ConvT (C) cells in the presence of anti-IFNγ or control IgG at different time
points. Each point represents the mean ±SD of three experiment performed. (D) Representative dot plots showing FoxP3 and Tbet expression in LP CD3+CD4+ T
cells of DSS-treated IFNγko and IFNγhet mice. Numbers in the dot plot quadrants represent the relative frequency of cell subpopulations.
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FIGURE 6 | (A) Body weight variation relative to the baseline of Treg-specific FoxP3 conditional knockout (FoxP3CreTbx21fl/fl) and control mice (FoxP3CreTbx21wt/wt)
upon DSS treatment. Results from one representative experiment out of four performed is shown (mean percentage ±SEM). (B) Endoscopic pictures and endoscopic
(Continued)
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FIGURE 6 | severity grading of knockout and control mice at the end of one representative experiment (Day 10). (C) Representative histological section from the
colons of FoxP3 knockout and control mice at the end of the experiment and cumulative histologic severity scoring of the experiment shown in (A). lcn-2 (D) and
cytokine (E,G) mRNA expression in the colon tissue of DSS-treated FoxP3 knockout and control mice. Vertical bars indicate the average ±SD analyzed in the pool of
mice from four independent experiments. (F) Fold change of cytokine mRNA expression, as indicated, in FoxP3 knockout mice relative to control mice. *p < 0.05;
**p < 0.01.
at the end of the DSS treatment and analyzed by flow cytometry.
As expected, Tbet-expressing FoxP3+ cells were virtually absent
in FoxP3CreTBX21fl/fl mice while about 20% of FoxP3+ cells
from FoxP3CreTBX21wt/wt control mice co-expressed Tbet
(Figures 7A,B). Interestingly, in TBX21 deficient mice, Tbet+
cells were also reduced by 3-fold among ConvT cells thus
indicating that the expression of Tbet in Tregs is required
for the development of Th1 cells in the inflamed colon. The
expression of IFNγ in ConvT cells was also significantly
reduced in the absence of Tbet-expressing Tregs (Figures 7C,D).
The reduced expression of Tbet and IFNγ resulted to be
specific for CD4+ ConvT cells since their expression remained
unaffected in CD8+ cells from FoxP3CreTBX21fl/fl inflamed
mice (Supplementary Figures 4A,B). Since LPMC from DSS-
treated FoxP3CreTBX21fl/fl mice showed reduced expression of
p35IL12, we wondered whether the defective induction of Tbet
in ConvT cells in the presence of Tbet deficient Tregs observed
occurred independently of innate immune cells. To this end, total
CD4+ T cells isolated from the spleen of FoxP3CreTBX21fl/fl or
FoxP3CreTBX21wt/wt control mice were polyclonally activated in
the absence of antigen presenting cells. After 12 h, the induction
of Tbet in ConvT cells from FoxP3CreTBX21fl/fl mice resulted
suppressed as compared to controls (Figures 8A,B). In keeping
with Tbet expression, IFNγ+ cells were significantly reduced in
both Tregs and ConvT cells from FoxP3CreTBX21fl/fl mice as
compared to FoxP3CreTBX21wt/wt cells (Figure 8C).
DISCUSSION
Tregs have been for long considered terminally differentiated,
phenotypically stable cells characterized by suppressive capacity.
Tregs are crucial for tolerance toward self and harmless
antigens. However, the observation that inflammation can
induce pro-inflammatory features in Tregs has challenged this
concept. The phenotypic changes that may affect Tregs in
different inflammatory conditions, are summarized by the terms
“stability” and “plasticity.” As for stability, it is meant the
loss of FoxP3 expression and the subsequent acquisition of
an effector phenotype (26–28). Although this phenomenon
has been observed in animal models of immune mediated
diseases, it might be circumscribed to a subset of not fully
differentiated Tregs in which room for reprogramming in
inflammatory conditions still exists (29). Nevertheless, Tregs
have been shown to transiently or permanently express T-helper-
master regulator transcription factors while maintaining FoxP3
expression. Though, the functional role of these phenotypical
changes remains unclear. The expression of Tbet in Tregs has
been shown to be required to efficiently control Th1 cells. Koch
et al. demonstrated that the IFNγ released in the inflammatory
environment induces Tbet in Tregs and that Tbet is required
for the expression of the chemokine receptor CXCR3 to address
Tregs at the site of inflammation where Th1 cells needs to be kept
in check (13). However, in other conditions, the expression of
Tbet in Tregs has been associated with the acquisition of a Th1-
like pro-inflammatory phenotype characterized by the expression
of IFNγ driven by IL12 signaling (14, 15).
The presence of Th1-like Tregs has been observed in different
pathologic conditions such as multiple sclerosis (MS) (18),
type 1 diabetes (T1DM) (17), autoimmune hepatitis after liver
transplant (30), and in animal models of intestinal inflammation
(19, 20). Although Tregs have been shown to accumulate in
patients affected by IBD, a direct characterization of Th1-like
Tregs in this pathologic condition and their functional role in
intestinal inflammation is currently missing.
In this study we showed that active IBD is characterized by the
accumulation of a sizable fraction of Tregs expressing both Tbet
and IFNγ. Since Th1-like Tregs were upregulated in inflamed
areas but not in patients with endoscopic disease remission or
in uninflamed controls, we hypothesized that Th1-like Tregs
could contribute to the inflammatory flares characterizing the
relapsing-remitting inflammation observed in IBD. To address
this issue, we investigated the role of Th1-like Tregs in the
dextrane sodium sulfate (DSS) model of colitis. Similarly to
human IBD, Th1-like Tregs accumulated in the inflamed colon.
In this model, the upregulation of Tbet and IFNγ in Tregs
preceded that of conventional CD4+ T cells (ConvT) and at
day 10 the number of Th1-like Tregs represented one third
of the total IFN-γ expressing CD4+ T cells. These findings
are in agreement with the data reported by Feng et al. in the
CBir-1 model of intestinal inflammation (19). In this model
the transfer of colitogenic naïve CD4+ T cells specific for the
immunodominant commensal antigen, CBir1 flagellin (CBir-
1Tg) but not of naïve CD4+ T cells from OTII mice which do
not induce colitis in immune-deficient TCRb/d−/− mice was
associated to the generation of IFNγ-expressing Th1-like Tregs.
Similarly, intestinal inflammation developing in TLR4- and IL10-
deficient mice was accompanied by the accumulation of Th1-like
Tregs. Thus, the induction of Th1-like Tregs characterizes the
development of intestinal inflammation and it can be reproduced
in different mouse models (20).
In agreement with previously published data, IFNγ was the
main inducer of Tbet in Tregs both in vitro and in vivo (13–
15). Indeed, the IFNγ neutralization in cell cultures of activated
CD4+ T cells and the analysis of IFNγ deficient mice treated with
DSS, demonstrated that IFNγ is required for the induction of
Tbet in the lamina propria Tregs. In contrast to Tbet expression,
IFNγ secretion by Tregs has been shown to be dependent on
IL12 stimulation and intracellular STAT4 activation. Indeed, the
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FIGURE 7 | (A) Representative dot plots showing FoxP3eGFP and Tbet expression in LP CD3+CD4+ cells isolated from the colons of Treg-specific FoxP3 conditional
knockout (FoxP3CreTbx21fl/fl) and control mice (FoxP3CreTbx21wt/wt). (B) Frequency of Tbet+ cells among LP Treg and ConvT cells from Tbet knock out and control
mice. (C) Representative dot plots showing IFNγ and Tbet expression in LP ConvT cells isolated from Tbet knockout and control mice. (D) Frequency of Tbet+IFNγ
cells among LP Treg and ConvT cells from Tbet knockout and control mice. Numbers in the dot plot quadrants represent the cell subpopulation relative frequency.
Horizontal bars in (B,D) indicate the mean value and symbols represent each animal analyzed from three independent experiments. *p < 0.05; **p < 0.01.
prolonged expression of Tbet in Tregs induces the activation of
the IL12 receptor locus in Tregs making these cells responsive
to IL12 and inducing the expression of IFN-γ (15). In our
in vitro system Tregs expressed IFNγ in the absence of IL12,
thus indicating that Tbet expression is sufficient to induce
the expression of IFNγ, not excluding the possible boosting
effect of IL-12 in these cells. Functionally, Tbet expression in
Tregs sustained intestinal inflammation since Treg-specific Tbet
conditional knockout mice showed milder colitis after DSS
treatment as compared to control mice. Tbet knockout mice
were characterized by reduced expression of Th1- but not Th17-
related cytokines. IL10, which has been shown to downregulate
IFNγ expression and to protect from colitis was not increased
in Tbet knockout mice (31). However, IL10 expression was not
altered in the Tbet knockout Tregs as compared to the wild type
controls. The phenotype of Tbet knockout mice was also unlikely
due to increased Tregs suppressive capacity since Tbet-deficient
Tregs were as suppressive as Tbet proficient Tregs both in vitro
and in vivo in the adoptive transfer model of colitis. However,
our data do not rule out the possibility that Tbet-expressing
Tregs isolated from the inflamed gut might permanently or
transiently lose their suppressive capacity further sustaining the
development of inflammation. Finally, the reduced expression
of IFNγ among lamina propria CD4+ T cells in DSS-treated
knockout mice was not restricted to Tbet-deficient Tregs but it
also involved conventional T cells, thus indicating that the Th1
immune response depends on the presence of Th1-like Tregs.
We exclude the possibility that the low Tbet expression in
ConvT cells results from a transient activation of the Foxp3 locus
during the differentiation of Th1 cells leading to the deletion of
Tbet in these cells. Indeed, by using FoxP3 fate mapping reporter
mice we were able to monitor the presence of T cells which
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FIGURE 8 | (A) Representative dot plots showing the expression of FoxP3eGFP and Tbet in CD3+CD4+ T cells from the spleen of Treg-specific Tbet conditional
knockout (Foxp3CreTbx21fl/fl) or control mice (Foxp3CreTbx21wt/wt) polyclonally activated in vitro for 12 h. (B) Frequency of Tbet+ cells gated on ConvT cells of
CD3+CD4+ T cells from Tbet knockout or control mice polyclonally activated in vitro for 12 h or left unstimulated. (C) Frequency of Tbet+IFNγ+ cells gated on Treg
and ConvT cells of CD3+CD4+ Tcells knockout and control mice as in (B). Numbers in the dot plot quadrants represent the relative frequency of cell subpopulations.
Horizontal bars in (B,C) indicate the mean value of results obtained from three independent experiments. **p < 0.01.
have transiently expressed FoxP3. In these mice the so called
“ex FoxP3+ cells,” marked by the permanent expression of the
tdRFP fluorescence even in the absence of FoxP3 expression,
represented a negligible fraction of CD4+ T cells and they
were excluded from the analysis. Moreover, the frequency of ex-
Tregs in Tbet knockout mice did not differ from controls thus
indicating that Tbet expression in Tregs does not influence Treg
phenotypic stability.
One possible interpretation of these results is that in the very
initial phase of inflammation Th1-like Tregs operate as enhancer
of the Th1 differentiation process. Different observations sustain
this hypothesis. First of all, the relative increase of Tbet-
expressing cells was higher among Tregs as compared to ConvT
cells in vitro and in vivo after DSS treatment. Moreover, the
induction of Tbet in Tregs preceded that of ConvT cells during
DSS treatment when histologic signs of inflammation were barely
detectable. Since the expression of Tbet by Tregs was dependent
on IFNγ, the ready induction of Tbet in Tregs as compared
to ConvT cells might be explained by the FoxP3-dependent
upregulation of IFNγ receptor in Tregs vs. ConvT cells (32).
Finally, the reduced expression of IFNγ observed in the lamina
propria of conditional knockout mice was not limited to the
absence of IFNγ-secreting Th1-like Tregs but it was associated
to a more general impairment of the Th1 immune response.
The role of Th1-like Tregs as enhancer of Th1 immune
response in the early phase of inflammation is also supported
by the observation that miR146-deficient Tregs, which are
characterized by the upregulation of STAT1-mediated
intracellular signaling and IFNγ expression, increased the
expression of Th1 cytokines in CD4+ T effector cells in a
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bone marrow chimera system (32). Moreover, the expression
of Tbet and IFNγ in Tregs contributed to the development of
Th1-mediated lethal disease in amodel ofT. gondii infection (16).
Interestingly, and in agreement with our data, the
upregulation of Tbet and IFNγ in Tregs induced by either
mir146 deficiency or T.Gondii infection did not affect Treg
suppressive activity thus confirming that the Th1 enhancer
activity exerted by Tregs during inflammation is not associated
with an impaired suppressive capacity.
The next fundamental question is how Th1-like cells enhance
the Th1 immune response. It is possible that IFNγ expressed by
Tregs directly contributes to the differentiation of conventional
Th1 cells in a paracrine manner. However, IFNγ could also
promote the differentiation of Th1 cells by upregulating the
expression of IL12 in dendritic cells. Accordingly, IL12p35 but
not IL23p19 was downregulated in the lamina propria of Tbet
conditional knockout mice.
In conclusion, based on our data, we propose a model in
which during the development of intestinal inflammatory flares,
Th1-like Tregs enhances the initial phase of inflammation by
promoting the development of Th1 cells. In this this context,
Th1-like Tregs would represent an another source of IFNγ-
producing cells involved in colitis development. Indeed, in
addition to the classic Th1 differentiation from a naïve T cells,
Th1 cells have been shown to derive from Th17 cells conversion
in different inflammatory conditions including colitis. Therefore,
the generation of Th1-like Tregs would represent just another
moment of a general Th1-skewing process involving different T
cell sub-types during the intestinal inflammation (33, 34).
At the same time, Tregs maintain their suppressive activity
on effector cell proliferation thus avoiding an excessive
inflammatory response. A dysregulation of this process, causing
a lower threshold of activation of the Treg-mediated pro-
inflammatory activity, might contribute to the generation of
chronic inflammation in the gut and to the pathogenesis of IBD.
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